Drug intelligence / Profile preview

Vagisan Moisturising Cream

Development stage: Unknown
Lead developer: Dr August Wolff
Administration: Topical, Vaginal

Overview

Vagisan Moisturising Cream is a non-hormonal, oil-in-water emulsion designed to treat symptoms of vulvovaginal dryness (VVD) and atrophy. Developed by Dr. August Wolff GmbH & Co. KG, it contains 23% lipids and is adjusted to a physiological pH of 4.5 using lactic acid. Unlike water-based gels, this cream provides both moisture and lipids to form a protective lubricating film on the vaginal and vulvar epithelium, preventing water loss and maintaining skin hydration. It is particularly indicated for women who cannot or choose not to use local estrogen therapy, such as breast cancer survivors experiencing treatment-induced menopause or genitourinary syndrome of menopause (GSM).

Brand names: Vagisan Moisturising CreamVagisan FeuchtCreme
Other names: Vagisan Moisturising Cream

Beyond the preview

Go deeper on Vagisan Moisturising Cream.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vagisan Moisturising Cream.

Explore the full profile